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EXECUTIVE SUMMARY 
 
 
Cirbo, Elizabeth Leigh. Hepatitis C Screening in Primary Care. Unpublished Doctor of 
Nursing Practice capstone project, University of Northern Colorado, 2017. 
 
 Primary care clinics are often the first stop when a patient has a question 
regarding health, needs screening for health conditions, and/or needs to complete 
maintenance healthcare items such as mammograms or colonoscopies.  As such, primary 
care providers are in prime position to screen for possible diseases that could poorly 
affect health for their patients.  These screenings are usually directed by guidelines and 
policies published through the National Guideline Clearinghouse (NGC) and the Agency 
for Healthcare Research and Quality (AHRQ; 2013).  One such guideline is entitled 
Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force 
(2013) recommendation statement.  This guideline recommends that all persons born 
between 1945 to 1965 be screened once in a lifetime for the Hepatitis C virus (HCV).  
The recommendation is because chronic HCV infection can lead to decreased quality of 
life and high cost of care for the individual and the healthcare system if left untreated. 
Untreated HCV can lead to liver cirrhosis and hepatocellular carcinoma.  A person who 
screens positive for infection with HCV can be appropriately treated and, in most cases, 
have complete disease eradication.  
 From the researcher’s clinical experiences, the screening processes in many 
primary care clinics in northern Colorado were lacking in numbers of patients screened 
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and provider knowledge of when to screen their patients.  The researcher developed a 
capstone project to implement at a primary care clinic through the use of three objectives:  
1. Increase screening rates for HCV at a primary care clinic 
2. Identify a barrier preventing providers from screening patients for HCV 
3. Overcome the barrier preventing screening for HCV 
Objective 1 was met through the use of an electronic medical record (EMR) 
review of patients who completed well-visits at the clinic before and after an educational 
seminar with the providers and staff at the clinic.  Objectives 2 and 3 were met through 
an educational seminar to identify and overcome barriers through the use of surveys and 
handouts, respectively.  The educational seminar allowed the researcher to offer 
screening coding tips to help with insurance coverage (as this was the barrier identified 
that prevented screening) and also to refresh providers and staff on the importance of 
HCV screening per the guideline for the birth cohort born from 1945 to 1965.  The EMR 
reviews of well-visits showed a 30% increase in screening rates for HCV at this clinic--
the pre-seminar rate was 37.8% and the post-seminar rate was 68.89%.  This shows the 
capstone project was a success to increase screening rates, identify a barrier preventing 
screening, and overcome this barrier.  Success of this capstone will have effects into the 
future as hopefully, the providers and staff continue to increase HCV screening rates for 
patients at the clinic.  The continued increase in screening rates could insure proper 
offering of treatment to patients identified as having positive HCV status to increase 
quality of life by preventing worse negative sequalae associated with chronic HCV 
infection.  
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CHAPTER I  
 
 
STATEMENT OF THE PROBLEM 
 
 
Introduction and Background 
Primary care providers (PCPs) have been called the gatekeepers to health care. 
Primary care providers are the first to assess a health situation and determine the best 
course of action.  As such, PCPs need to be well-versed in many diagnoses and plans of 
care for such diagnoses as well as be able to provide a thorough well-check or annual 
physical.  The recently enacted Affordable Care and Safety Act mandates insurances pay 
for more preventative medicine to save costs involved in caring for chronic, highly-
progressive diseases and have a healthier population in general.  This results in more 
people getting annual well-exams and completing preventative and screening healthcare 
protocols.  Some of these protocols include primary interventions like influenza and 
shingles vaccinations and education on healthy lifestyles to try to circumvent disease. 
Other secondary surveillance methods include screenings for various diseases as 
indicated.  Common blood work included in typical screenings at a PCP office are lipid 
levels, thyroid tests, and metabolic panels to screen for cholesterol imbalances, hypo- or 
hyper-thyroid disease, and glucose and electrolyte imbalances.  Other screenings include 
colonoscopies, mammograms, and pap smears to screen for colon cancer, breast cancer, 
and cervical cancer.  
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Most primary care offices adhere well to these screening and prevention 
recommendations from the Centers for Disease Control and Prevention and the National 
Guideline Clearinghouse (NGC), which is operated by the Agency for Healthcare 
Research and Quality (U.S. Preventive Services Task Force [USPSTF], 2013).  Many of 
these protocols and recommendations were developed by experts in each field as well as 
based on meta-analysis of research on the associated topic.  Most of these screening 
recommendations come from the NGC and are graded upon evidence and outcomes as A 
through I--where A is supported by the most evidence and highly recommended with 
benefits outweighing risks and I is not recommended as not enough evidence is available 
to support implementation (USPSTF, 2013).  One such grade B recommendation is for 
adults born from 1945 to 1965 be screened for HCV once in a lifetime with a potential 
for rescreening based upon high-risk behaviors or receipt of a blood transfusion before 
1992.  This grade B recommendation is perceived as having moderate net benefit in 
preventing further clinical poor outcomes related to HCV as well as preventing further 
spread of disease and providing opportunities to teach about this disease process 
(USPSTF, 2013). 
 Hepatitis C virus is spread from bodily fluid contact and is a mostly preventable 
disease.  According to McCance, Huether, Brashers and Rote (2010), HCV is the most 
common cause of chronic liver disease in the Western world; it is contracted through 
contact of bodily fluids and 40% of cases are from intravenous drug users (p. 1489).  As 
such, HCV is largely preventable and now also treatable, especially when detected early. 
For the birth cohort of adults in the United States born between 1945 and 1965, it is 
recommended each individual be screened for HCV at least once in their lifetime even if 
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asymptomatic of liver disease or abnormalities (USPSTF, 2013).  The guideline has 
determined it to be important for this population to be screened due to high risk for 
transmission of disease from possibly receiving a blood transfusion before HCV was part 
of the universal screening in blood products and the possibility of transmission from 
high-risk behaviors in younger years such as multiple sexual partners, unprotected 
intercourse, and/or intravenous drug use (USPSTF, 2013).  This birth cohort is at higher 
risk for these behaviors partly due to living through the 1970s and 1980s when previously 
mentioned high-risk behaviors were a common part of the lifestyle.  
 It is recommended this birth cohort be screened because untreated HCV can cause 
major negative health sequelae for the individual as well as being unknowingly 
transmitted to other persons through sexual contact and intravenous drug use.  
Undetected and, thus, untreated HCV causes an increased cost load on the healthcare 
system to treat the negative health sequalae of HCV disease progression.  Proper 
screening and treatment helps prevent decreased quality of life for those infected with the 
advanced untreated disease.  By implementing a screening process for the birth cohort 
born from 1945 to 1965, those who received a blood transfusion before 1992, and high 
risk individuals, the cost on the healthcare system could be decreased and more adults 
could have increased quality of life with less negative health sequelae from HCV.  
 As an Advanced Practice Registered Nurse (APRN), preventing illness and 
limiting negative outcomes from disease process are key to holistic care provided by 
nurses.  Implementing HCV screening in primary care for the aforementioned 
populations is one simple addition to routine health screenings that could have a large 
impact on individual health care, a population’s health, and associated healthcare costs.   
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 Hepatitis C virus is a disease that in its early stages, even in a chronic disease 
state, is often times asymptomatic. According to the American Association for the Study 
of Liver Disease-Infectious Diseases Society of America (AASLD-IDSA; 2015), 
approximately 2.2 to 3.2 million persons are infected with HCV in America and about 
half do not know they are infected.  To decrease transmission rates and increase 
treatments rates, proper screening methods must be adhered to in primary care settings. 
Screening for HCV is a simple blood test but is not often offered to patients.  This can be 
due to lack of knowledge by providers to implement this screening (Bechini et al., 2015), 
lack of time in office visits for providers, or lack of knowledge of treatment if results are 
positive from a screening test.  
The practice setting for the capstone was a primary care clinic (PCC) located in 
Greeley, Colorado.  This practice has five providers: four medical doctors (MD) and one 
family nurse practitioner or APRN.  Two of the doctors are full-time at the clinic, one is 
there one day per week, and one is an on-call position, filling in on an as-needed basis. 
The APRN sees patients four days per week.  The clinic cares for adult patients with 
chronic illnesses such as chronic obstructive pulmonary disease, diabetes mellitus, and 
asthma among other chronic conditions.  The providers serve as patients’ primary care 
providers (PCP) for well-visits and episodic visits as needed.  The PCC focuses on 
quality of life for patients through preventive care and management of chronic disease. 
This capstone project focused on improving rates of screening for HCV by identifying 
and overcoming barriers to screening.  
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Population, Intervention, Comparison, Outcome,  
and Time Statement 
 An analysis of current practice of HCV screening in the PCC and many family 
practices in the Northern Colorado area found HCV screening for this particular birth 
cohort was not routinely offered or completed.  Although HCV is not a diagnosis to make 
lightly, it is better to diagnose and treat it than let it go unmanaged, leading to chronic 
liver disease.  By implementing standardized screening mechanisms for HCV for PCPs, 
the goal was to identify otherwise undiagnosed cases of HCV to reduce negative health 
sequelae and decrease healthcare costs.  
Barriers to screening for HCV in primary care include time limitations with 
patients, little or no knowledge of HCV screening guidelines, and lack of knowledge of 
how to treat a patient with a positive screen.  The target population of this capstone was 
patients in the birth cohort from 1945-1965 and high-risk patients: those who have in the 
past or are currently using intravenous drugs, patients who have been incarcerated, 
patients who engage in risky sexual behaviors, and patients who received a blood 
transfusion before 1992 (USPSTF, 2013).  The researcher evaluated if screening was 
completed at well-visits over a three-month time period through a chart review of the 
electronic medical record (EMR) for the specified patient population.  The desired 
outcomes of the capstone were increased rates of screening and identification and 
dismantling of barriers to screening for providers.  Thus, this project answered the 
PICOT question: For patients born from 1945 to 1965, is appropriate screening offered 
for HCV routinely at the PCC compared to no screening process to improve screening 
rates after implementing a process change in a three-month time span? 
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Review of Literature 
 A literature review was conducted to evaluate current research, barriers to 
screening, and solutions to HCV screening utilizing CINAHL and PubMed databases, 
UpToDate, the Agency for Healthcare Research and Quality (AHRQ), and text books. 
While searching digital search engines, MeSH terms were used including hepatitis C, 
mass screening, and costs and cost analysis.  This researcher reviewed multiple articles 
about this subject matter.  The research yielded much information regarding HCV 
screening, the benefits of screening that could lead to early treatment, and barriers to 
treatment.  
 Hepatitis C virus is a disease that comes from bodily fluids being shared from an 
infected person to an uninfected person.  According to Sanjiv, Bisceglie, and Bloom 
(2016), chronic HCV is often asymptomatic in many patients or the symptoms can be 
vague, e.g., arthralgia and fatigue.  Vague symptoms lead to underdiagnoses for many 
patients or lack of recognition of an issue to report to the PCP for diagnosis and 
treatment.  Chronic HCV infection can then lead to cirrhosis of the liver within 20-30 
years, the leading cause of liver transplant in the United States of America (Sanjiv et al., 
2016).  This deterioration of the liver over time through misdiagnosis or missed diagnosis 
increases healthcare costs for patients and the healthcare system while decreasing quality 
of life for patients.  Treatment of HCV with direct-acting antivirals (DAAs) is becoming 
more easily accessible and has revolutionized care of HCV to eradicate it completely 
from the host (Brouard et al., 2015).  
 Negative sequalae associated with chronic HCV infection include cirrhosis, liver 
failure with ascites, hepatic encephalitis, esophageal varices, and hepatocellular 
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carcinomas (Howie & Hutchinson, 2004).  Upon utilizing a computer-generated model, 
Howie and Hutchinson (2004) utilized current data of HCV infection rates to estimate a 
cost burden of HCV if there was no process change of recognition and treatment of HCV. 
The CDC (cited in Howie & Hutchinson, 2004) estimated the direct cost of care for 
chronic liver disease in the United States would be approximately $10.7 billion and 
indirect costs from associated mortality and morbidity of cirrhosis would be 
approximately $54 billion.  Although the cost of treatment with the preferred method of 
pegylated-interferon and ribavirin is costly, the cost of initial treatment is much less than 
the future burden of a large population of undiagnosed HCV patients developing cirrhosis 
or hepatocellular cancers (Howie & Hutchinson, 2004).  As a comparison of costs from 
HCV developing into hepatocellular carcinoma or cirrhosis leading to liver transplant, the 
cost of a liver transplant is estimated to be $103,548 and the five-year cost for a person 
diagnosed with hepatocellular carcinoma is $106.4 million (Smyth et al., 2014).  With the 
baby-boomer generation (the birth cohort born 1945-1965) having a high undiagnosed 
infection rate for HCV and if the majority of the undiagnosed cases of HCV develop into 
cirrhosis, end-stage liver disease, or hepatocellular carcinoma, the cost burden to patients 
and the healthcare system could be astronomical.  
To prevent the development of HCV into cirrhosis, hepatocellular carcinoma, and 
end-stage liver disease for this large population, it is imperative to screen appropriately. 
This ensures HCV can be quickly diagnosed and treated with DAAs to eradicate disease 
(Smyth et al., 2014).  Gane et al. (2015) extrapolated data about aggressive screening, 
diagnosis, and treatment rates of 16 different countries.  The data showed increasing 
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screening and treatment three- to five-fold would dramatically decrease healthcare burden 
costs of HCV (Gane et al., 2015). 
 However, one barrier to adequate screening and, thus, diagnosis and treatment of 
HCV is provider awareness of appropriate screening.  Bechini et al. (2015) conducted a 
semi-quantitative study in six European countries of providers regarding knowledge of 
guidelines about screening for HCV.  A survey was developed by the researchers and 
sent to various healthcare providers with diagnosis and treatment scope of practice to 
determine knowledge of screening guidelines for HCV; 56% of the providers surveyed 
knew of national guidelines regarding HCV (Bechini et al., 2015).  The survey results 
also found if providers were screening and received positive results, treatment and 
appropriate referral rates were low (Bechini et al., 2015).  This exemplifies the need for 
increased awareness of screening guidelines as well as appropriate treatment upon 
positive screening.  
 The cost of screening is relatively minimal.  A local laboratory in northern 
Colorado, Horizon Laboratory (2016), offers direct access testing to any person in 
Colorado at a fee-for-service cost of $45; the testing does not require an order by a 
provider so a patient might complete tests as desired.  This is a minimal cost compared to 
possible negative health sequalae related to chronic HCV infection progressing to one of 
the aforementioned disease processes.  Also, most insurances cover preventative lab work 
such as the screening previously discussed.  According to Alter, Kuhnert, and Finelli 
(2003), laboratory costs to conduct an anti-HCV test are as follows excluding the 
payment of laboratory personnel, facility usage, etc.: “$5/sample for initial screening test, 
$15/sample for those testing initially reactive and repeated in duplicate,” and “$50-
9 
 
$295/sample with reflex recombinant immunoblot assay RIBA and or nucleic acid test 
testing (NAT)” (Estimated Costs, para. 4).  The reflex testing is lab and provider specific; 
however, if a screening anti-HCV test is positive, reflex RIBA or NAT testing must be 
completed to confirm positive HCV infection (Alter et al., 2003).  
 Another factor of HCV screening to consider is the sensitivity and specificity of 
the test.  When screening is ordered, the USPSTF (2013) recommends Hepatitis C 
Immunoglobulin G antibody as the test of choice for chronic HCV.  This test works by 
testing blood serum for antibodies to HCV in the patient (Sanjiv et al., 2016).  Per Alter 
et al. (2003), if an anti-HCV test is positive, reflex testing is recommended to confirm a 
positive HCV infection.  The anti-HCV test is completed with various manufacturers’ 
machinery utilizing enzyme immunoassays (EIA) or enhanced chemiluminescence 
immunoassay (CIA; Alter et al., 2003).  When utilizing EIA testing for anti-HCV, the 
specificity is >99%; however, among immunocompromised patients, false-positive 
results can be as high as 15%.  Due to the possibility of false positive, the CDC (cited in 
Alter et al., 2003) recommends reflex testing with RIBA or NAT to confirm a positive 
screening test.  
 After thorough appraisal of existing research, HCV screening has proved to be an 
effective use of healthcare costs with positive benefit to the patient and healthcare system 
as an outcome.  The risk of screening is minimal compared to benefits gained from early 
identification of disease as are the treatment costs compared to the costs of late stage 
disease treatment.  As recommended by the AHRQ (2013), routine screening is beneficial 
to individual patients, the healthcare population, and the healthcare system.  The research 
showed evidence that HCV is treatable; the earlier the diagnosis is made, the better the 
10 
 
prognosis and lower cost compared to late stage disease treatment and care (see 
Appendix A for literature review table).  
Theoretical Framework 
 For this capstone project, Lewin’s change theory (Petiprin, 2016) guided the 
researcher in identifying barriers to change in the PCC, developing an action plan to 
overcome the barriers, and implementing new changes regarding the screening process 
for HCV in the birth cohort born 1945-1965.  It is important to utilize theory to guide 
practice changes as changes within a clinic can be cumbersome to staff and providers 
alike.  This theory gave a pathway to increase likelihood of acceptance and implication of 
changes regarding new practices.  
Lewin’s change theory (Petiprin, 2016) utilizes three major concepts: driving 
forces, restraining forces, and equilibrium; and three major stages: unfreezing, change, 
and refreezing.  Driving forces bring changes and shift the equilibrium; restraining forces 
hinder and oppose change; equilibrium is a state where no change is occurring as the 
driving force and restraining forces are equal (Petiprin, 2016).  The stages of change 
begin with unfreezing--when old patterns are released and resistance is overcome. 
Change is the moving piece; thoughts, feelings or behaviors change the workflow to be 
more productive.  Re-freezing is when the new habit or process becomes the standard 
operating procedure (Petiprin, 2016). Figure 1 shows the change stages. 
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Figure 1.  Stages of change according to change theory (O’Loughlin, 2013). 
 
 Applying the stages of change to overcoming barriers was a challenge as the 
barriers for the different providers in the clinic were different.  By having an educational 
seminar or lunch and learn, this researcher identified whether the clinic valued the role of 
HCV screening enough to want to change or unfreeze the patterns regarding HCV 
screening and change and refreeze into a pattern that utilizes HCV screening regularly. 
The method to change the process regarding HCV screening was also varied depending 
on what the barriers were and at what level the changes needed to be implemented, i.e., 
system level or personal level.  
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CHAPTER II  
 
 
PROJECT DESCRIPTION 
 
 
Project Objectives and Timeline 
 
 This capstone project was designed to implement evidence-based practice and 
theory into practice.  The goal of the project was to improve screening rates of HCV 
within the primary care clinic for high-risk populations including the birth cohort 
previously mentioned.  This capstone project utilized a multiphasic approach to assess 
current screening rates, implemented a new process to improve appropriate screening 
measures, and re-evaluated screening rates post-implementation of screening tactics.  
Project objectives included 
1. Increase screening rates for appropriate patients for HCV. 
2. Identify barriers to screening.  
3. Develop action plan to overcome barriers to screening.  
 The first objective of this project was to complete a medical record review of the 
patients at this clinic to determine if appropriate HCV screening was occurring.  This 
mainly focused on the birth cohort but also included high-risk patients, which were sorted 
from the clinic population using the EMR.  The researcher reviewed well-visits within a 
three-month period to examine if patients were screened for HCV at the well-visits in the 
past, if they met criteria for screening, if they were offered HCV screening, or if there 
was a documented refusal of screening.  This established a base number of patients at the 
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primary care clinic who had been screened or were offered screening.  This also showed 
if the providers were offering screening appropriately.  
 Barriers to screening were identified through a lunch and learn for the providers at 
the primary clinic provided by this researcher (see Appendix B for flyer).  The lunch and 
learn focused on guideline recommendations for HCV screening and the importance of 
screening for high-risk patients--mainly the patients in the birth cohort (USPSTF, 2013).  
After the lunch and learn, the researcher followed up with providers to discuss their 
views and opinions regarding barriers to screening if needed.  From this lunch and learn, 
this researcher developed a plan to follow up on commonly mentioned barriers to assess a 
full picture of why HCV screening was not routinely offered or conducted--barriers like 
lack of knowledge of how to screen or how often to screen, provider attitude, distrust of 
guidelines, time restrictions, etc.  The researcher also followed up with personal 
interviews as needed to clarify barriers, which allowed the researcher to synthesize which 
barriers were possible to overcome and which barriers were insurmountable.  Part of the 
efficacy and effectiveness of the lunch and learn was measured by a pre-seminar survey 
about HCV screening and asking about barriers (see Appendix C), which was followed 
by a post-seminar survey (see Appendix D).  A consent form for human participants in 
research was attached to each survey (see Appendix E). 
The third objective of developing an action plan to overcome barriers to screening 
depended on what the focus group forum and surveys of the providers revealed as 
hindrances to screening for HCV.  If it was time constraints of appointments, then 
administrative changes could be attempted.  If lack of knowledge of what to do after 
screening was a barrier that prevented screening from happening, then an education 
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session could be scheduled to increase knowledge and comfort with what screening 
results meant and how to appropriately treat.  As stated previously, overcoming barriers 
through an action plan would depend upon the results of the survey and what the follow-
up conversations about HCV screening revealed.  
Evidence-Based Project Plan 
 Completing a chart review of HCV screening at well visits provided a baseline of 
screening rates for the primary care clinic.  The follow-up lunch and learn discussions 
with accompanying surveys helped the researcher discern barriers to screening rates and 
guide an action plan for overcoming these barriers to increase screening rates.  
Phase One 
Phase 1 addressed objective one, which was to increase HCV screening rates for 
appropriate patients.  The objective entailed obtaining a baseline rate of screening for 
well-visits at this clinic to compare later to the post-focus group about barrier rates of 
screening.  To obtain the baseline to calculate an increase of screening rates, the 
researcher reviewed the EMR for all patients in a three-month time period who visited the 
primary care clinic for a well-visit for evidence of HCV screening in the past, at the 
appointment, or a documented refusal of screening.  The patients’ EMR review was for 
all patients in the birth cohort of 1945-1965 or a documented history of intravenous drug 
use or other high-risk behavior over the age of 18.  As this project was focused on 
barriers for providers to screening, a simple table was developed. 
 As the focus of the objective was to help providers increase their rates of 
screening, a “yes” response included documentation of previous screening as long as it 
was addressed by the provider (this demonstrated awareness of the need for HCV 
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screening), a current order of blood work to screen for HCV, and documentation of 
discussion of the importance of HCV screening between a provider and a patient.  
Phase Two 
Phase two addressed objective two--identify barriers to screening.  During this 
phase, this researcher educated staff and providers of who to appropriately screen for 
HCV.  This lunch and learn discussed USPSTF’s (2013) guideline recommendation 
regarding HCV screening, the importance of appropriate screening, and possible disease 
burden reduction that could come from appropriate screening and treatment.  During the 
lunch and learn, the researcher recorded and took notes regarding providers’ concerns 
and questions about barriers that decreased screening rates of HCV as well as utilized 
surveys to assess knowledge.  The researcher developed and distributed pre- and post- 
lunch surveys to the providers regarding the most discussed barriers to screening as well 
as a section on the survey for “other” barriers not included in the survey.  The surveys 
were further extrapolated for clarification to fully understand and be able to create a 
change method for overcoming the barriers.  
Phase Three 
The third phase of the project addressed objective three--develop an action plan to 
overcome barriers to screening.  This phase utilized the results of the surveys and 
discussions to determine one or two barriers most often recognized by providers to 
develop changes to the practice to make screening more feasible at the primary care 
clinic.  This phase also included implementation of a barrier breaker.  After the barrier 
change implementation occurred, the researcher waited approximately eight weeks to 
reassess if the change was working to increase screening rates for HCV.  This 
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reassessment was evaluated by a repeated chart review of well-visits from the eight 
weeks after the barrier change was implemented.  The number of screenings were then 
compared to the baseline comparison of EMR reviews captured in phase one.  
Congruence 
 This primary care clinic is part of a larger healthcare system located in the 
Western region of the United States of America.  The mission of the system is to provide 
excellent patient care.  Part of providing excellent patient care is to circumvent disease or 
decrease disease burden when possible to increase quality of life.  Increasing screening 
rates for HCV complies with the mission of the organization by decreasing harm to 
patients.  
Timeline 
 This capstone project began on December 2, 2016 with a capstone proposal 
defense.  The researcher obtained approval from the University of Northern Colorado’s 
Institutional Review Board to conduct the research (see Appendix F).  After this 
approval, the project was also approved by the primary care clinic’s organization research 
body (see Appendix G); a Statement of Mutual Agreement was also obtained (see 
Appendix H). 
Phase one was a retrospective chart review of the EMR that began in March 2017.  
The retrospective chart review took approximately one month.  This was happening 
concurrently with phase two that began in March 2017 as well. The lunch and learn 
occurred during this time period as well as surveying the providers to discover barriers to 
screening practices.  Phase three began after the lunch and learn and survey completion in 
March 2017.  The selected barrier was utilized to create an action plan to overcome it to 
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increase screening rates.  After implementing the action plan to overcome the barrier, the 
researcher waited eight weeks to reassess the HCV screening rates by again utilizing an 
EMR review.    
Resources 
 The resources utilized for this project included the providers at the clinic (two 
medical doctors and one family nurse practitioner who practice full time and two per 
diem doctors), a nurse case manager who helped with chart review and identified high- 
risk patients, and the office manager and information technology specialists.  The 
information technology specialists were also good resources for data mining within the 
EMR review.  Potential barriers to implementing this evidence-based capstone project 
included unfamiliarity with the charting system to be able to conduct a thorough chart 
review, inadequate time to conduct a thorough chart review, and resistance to HCV 
screening by patients.  Benefits to conducting this study included increased screening 
rates, which could lead to increased identification of HCV and, thus, adequate treatments 
to decrease poor outcomes and reduce healthcare costs.  
 Capstone committee members were also resources who were utilized during the 
capstone.  Karen Hessler, Ph.D., FNP, MSN, RN was the capstone chair and was vital to 
the success of the project.  Katrina Einhellig, Ph.D., RN, CNE served as a committee 
member and was valuable to research and evidence-based practice changes.  Maribeth 
Taylor, MSN, FNP, RN served as the outside committee member and was employed at 
the primary clinic where the capstone research occurred.  
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Stakeholders 
 Stakeholders for this project included the University of Northern Colorado; the 
School of Nursing, the Graduate School, and the committee members for the capstone 
were especially invested as stakeholders. At the primary care clinic, stakeholders 
included the providers, especially Maribeth Taylor, the FNP onsite; the Medical 
assistants (MAs); case managers; and the office manager.  The patients also stood to gain 
from this capstone as it could circumvent problems via early disease detection and 
treatment.   
Strategic Analysis 
 Strategic analysis of the capstone project was through utilization of a strengths, 
weakness, opportunity, and threats (SWOT) tool, which allowed the researcher to analyze 
how well the implementation of overcoming barriers to screening HCV worked.  
Strengths of conducting this project included desire for increased screening rates, 
which could lead to increased identification of HCV and adequate treatments to decrease 
poor outcomes and reduce healthcare costs.  This project also follows a national guideline 
developed by experts in the field of hepatology.  The capstone also utilized the strength 
of conducting research in a clinic part of a bigger system, which offered more resources 
to utilize in overcoming barriers.  
Potential weaknesses to implementing this evidence-based capstone project 
included unfamiliarity with the charting system to be able to conduct a thorough chart 
review, inadequate time to conduct a thorough chart review, resistance to HCV screening 
by patients, and resistance by providers to implement changes.  
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Opportunities within this capstone included increased quality of patient care, 
increased provider satisfaction and safety in following appropriate guidelines, and 
potential decreased burden on the healthcare system.  Threats to the capstone included 
provider resistance, time constraints, and possible resistance to learning and changing 
habits.  
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CHAPTER III 
 
 
EVALUATION PLAN 
 
 
Project Evaluation 
 
The objectives of the capstone were to increase screening rates for appropriate 
patients, identify barriers to screening, and overcome barrier(s) to increase screening 
rates.  The project was evaluated in three phases over approximately five to six months.  
Phase One  
Initial surveillance of the program included a medical chart record review of three 
months’ worth of well-visits for all providers at the primary care clinic.  The table 
depicted in Figure 2 in Chapter II served as the data collection tool for the EMR review.  
During this EMR review, a systematic review surveyed for appropriate patients to screen 
for Hepatitis C.  These appropriate patients included the birth cohort of people born 
between 1945 and 1965 per the target population of the guideline (USPSTF, 2013). 
During this EMR review, the table’s category of HCV screening ordered included 
information about whether the patient was offered screening with the provider at the well 
visit and thus completed.  The results were interpreted as percentages of screenings 
offered and completed.  The screening rates were determined by comparing total 
population of well-visit patients seen by providers in the three-month period in the birth 
cohort surveyed by this researcher.  The researcher then created percentages of the pre- 
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and post- educational seminar surveys to analyze the data pulled from the EMR at the 
primary clinic.  
Phase Two 
As previously stated, a lunch and learn was facilitated by this researcher regarding 
the importance of HCV, which patients were appropriate for screening, and appropriate 
treatment to follow upon a positive screen.  Following the short educational forum, this 
researcher followed up with discussion of perceived barriers to screening at the clinic. 
This discussion was reviewed by this researcher who utilized a follow-up survey to delve 
deeper into why the issues were barriers to implementing HCV screening.  The survey 
also included room for other barriers not mentioned in the forum to be accounted for so 
this researcher could have a full picture of what barriers prevented appropriate screening 
from occurring.  
Phase Three 
After teaching about the NGC (USPSTF, 2013) guideline and surveying the 
providers at the primary care clinic, the researcher selected one barrier to screening rates 
and developed an action plan to overcome that barrier to improve screening rates.  The 
action plan depended on the lunch forum discussion of barriers and the post-seminar 
survey to address the most common barriers.  After implementing the action plan to 
overcome the barrier, the researcher waited eight weeks to allow the action plan to be 
implemented and change the screening process at the primary clinic. After the eight 
weeks, the researcher re-surveyed all well-visits within this time span for a medical chart 
review regarding the rates of appropriate screening for patients seen at the primary clinic.  
The table depicted in Figure 2 was once more utilized to provide descriptive data about 
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screening rates.  The descriptive statistics were then compared to pre-implementation 
rates collected in phase one.  This statistical comparison showed an increased percentage 
of screenings, thereby successfully overcoming the barrier identified by the researcher 
and the providers.    
Method Analysis 
 To provide statistical significance to this project, data recorded from the chart 
survey were analyzed and converted into a percentage of patients screened compared to 
the number of patients who met criteria but were not screened.  This provided a baseline 
of potential screening opportunities missed.  As previously mentioned, a similar medical 
chart review was also conducted after the education when barriers were identified and 
overcome.  The desired statistics were gathered using the data collection table.  
 To evaluate the process of identifying barriers and overcoming them at the 
primary care clinic, nursing change theory was used to evaluate the practice change in the 
phase it now resided.  Although, a specific framework was not used to apply the statistics, 
the database created and maintained from the pre-barrier breakdown implementation 
versus the post-barrier breakdown period provided numerical value to the statistical and 
clinical significance of the HCV screening process in the primary care clinic.   
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CHAPTER IV 
 
 
RESULTS AND OUTCOMES 
 
 
 The objectives of this capstone project were to increase screening rates for HCV 
in the 1945-1965 birth cohort at a primary care clinic in Northern Colorado, identify 
barriers to screening in a primary care clinic, and overcome barriers to improve screening 
rates.  This chapter presents the results of the planned evaluation as outlined in Chapter 
III.  To meet the objectives, this researcher utilized an EMR review of patients seen in a 
three-month time period before the lunch and learn seminar who met the criteria of being 
born in the birth cohort to check for a baseline screening rate.  This method helped to 
determine baseline screening rates in order to have a rate to compare to the post-lunch 
and learn seminar and implementation of an action plan to increase screening rates.  
Results Linked to Problem Statement  
and Evaluation Plan 
 On March 8, a lunch and learn educational seminar was given to the providers and 
staff at the clinic.  Two weeks prior to the seminar per discussion with the manager, a 
date was set for the seminar and all clinical staff and providers received an email from the 
manager regarding the date and time of the lunch.  Prior to the seminar, the researcher 
met with the nurse practitioner who was part of this capstone project committee and the 
clinic manager to discuss potential barriers at the clinic in order to be better prepared for 
the seminar.  Concerns included time spent with patients and mainly a billing and coding 
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concern.  Per the manager, screening diagnosis codes assigned to screening lab orders, 
like the Hepatitis C antibody test, were not being accepted by Medicare as valid codes for 
screening and preventative testing.  Patients were then getting charged for the lab testing 
when usually screening lab work is covered by insurance companies.  This created a 
challenge in how to bill and appropriately code for screening lab work like the HCV 
antibody test. 
 As previously stated, a chart audit of the EMR was performed on all well-visits 
for patients in the birth cohort for a three-month time period prior to the lunch and learn 
seminar and the subsequent action plan at the primary care clinic.  To get an accurate 
random sample of patients from the birth cohort, a list was compiled of all patients seen 
by the five providers at the clinic in the three-month time period.  The majority of the 
patients were seen by two doctors of the five providers who work at this clinic full time, 
followed by patients seen by the full-time nurse practitioner; a small amount of the 
patients was seen by the other two doctors who were only at this clinic one to five times 
per month depending on the scheduling needs of the clinic.  This query for patients 
initially totaled over 2,200 patients.  This list was then sorted by “schedule reason,” 
meaning the reason the patients scheduled the appointment.  For this chart audit, all 
episodic, acute, or “sick” reason appointments were excluded from the chart audit.  This 
left all patients scheduled to see a provider based on the reason of well-visits or annual 
physical appointment.  The list was then further limited by the age of the patient.  All 
patient charts were removed from the list of potential audits if they did not meet criteria 
of being born between 1945 and 1965. For the three-month period, 124 patient charts 
remained to be audited.  
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According to the manager of the clinic, the total number of established patients at 
the clinic who are in the birth cohort was 317 (Personal communication, 2017).  The total 
number of patients within the birth cohort (born from 1945-1965) was 317.  The sample 
population of well visits between November to January was 124 patients.  This meant 
approximately 39.1% of the total birth cohort population at the clinic was represented in 
the chart review. Of the 124 patient charts that were audited for whether HCV screening 
was completed, 47 of the patients were screened within the last two years for HCV or 
were able to verbalize a negative screen in the past and the provider documented as such. 
This yielded a 37.9% positive screen rate for the sample of the birth cohort seen by 
providers at well visits for a three-month period.  
 For the data collection from the EMR, the time period of the three months prior to 
the lunch and learn, the data review sample population was limited to just patients who 
came to the clinic for a well visit.  Hepatitis C virus screening could be ordered and 
completed at any appointments other than a well-visit.  The review of well-visit data 
revealed one of the three main providers consistently included discussion and offering of 
HCV screening to the birth cohort; the other two main providers either did not document 
the discussion or did not offer it to their patients.  During the three-month time frame, the 
two part-time providers at the clinic worked a total of 10 days each; thus, a majority of 
the patients were seen by the three main providers.  After the lunch and learn seminar, 
one of the part-time providers resigned from the clinic.  The two part-time providers did 
not consistently offer, document, or discuss HCV testing for patients in the target 
population during well visits.  
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 For the post lunch and learn eight-week chart review, the sample size of the total 
birth cohort was 45.  Therefore, the sample population was 14.19% of the total birth 
cohort at the clinic.  The chart review revealed that 31 of the 45 well visits in the birth 
cohort were screened for HCV at their well-visit.  Having 31 patients screened yielded a 
68.89% screening rate for patients within the birth cohort.  The screening rate prior to the 
lunch and learn was approximately 37.9%.  This was a 30.99% increase in the sample of 
the birth cohort being screened for HCV.  Table 1 shows the results of the screening rates 
prior to the lunch and learn seminar compared to the post seminar screening rates after 
addressing the barrier of coding.  
 
Table 1 
Comparing Screening Rates Prior to and Before the Seminar 
 Prior to Seminar Post Seminar  
Total Patients Reviewed N = 124 N = 45 
Patients Screened for HCV N = 47 (37.8%) N = 31 (68.89%) 
 
 
 
 While also discussing information with the manager and NP at the clinic 
regarding potential barriers preventing HCV screening, the researcher found the common 
barrier for HCV screening was the billing and coding issue.  From this information, the 
researcher developed two surveys for use at the lunch and learn seminar to evaluate 
understanding of the topic.  The researcher also developed two handouts for the staff at 
the seminar that educated about HCV screening and potential coding information to assist 
in ordering the screening.  The coding informational handout was developed by the 
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researcher with consultation from the coding specialist onsite for the clinic.  Survey 1 can 
be found as Appendix C.  Survey 2 can be found as Appendix D.  The coding handout 
can be found in Appendix I.  The HCV informational handout can be found in Appendix 
B.  Survey 1 was given to all in attendance before beginning the seminar and collected by 
the researcher. Then the handouts were given to all attendees and the researcher gave a 
short presentation about the HCV screening guideline pertaining to the birth cohort and 
allowed time for questions. The intervention discussed to help improve screening rates 
was in relation to coding appropriately.  The coding handout was referenced.  All in 
attendance were allowed to ask clarifying questions and verbalized understanding of the 
improved coding options.  Following the presentation of information and answering of 
questions regarding the coding process, the researcher gave all attendees the second 
survey.  In total, the meeting attendees included the three main providers of the clinic, the 
clinic manager, a laboratory technician/phlebotomist who is a full-time employee of the 
clinic, and three medical assistants (MAs) for a total of eight participants.  
Preliminary barriers identified from the discussion at the seminar revealed mainly 
concerns about how to code the appointment appropriately for the screening tests to avoid 
patients being billed directly for the screening.  After discussing the handouts that 
included helpful coding information, all attendees verbalized no further questions at this 
time and agreed that HCV testing should be offered to any patient who met criteria.  All 
in attendance were able to successfully identify the correct test for HCV screening (HCV 
antibody) and which patient population met guideline recommendations for once in a 
lifetime screening (birth cohort from 1945 to 1965).   
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Survey data was compiled by the researcher.  Survey 1 had eight completed 
surveys returned to the researcher.  Only seven of Survey 2 were returned to the 
researcher.  Table 2 shows the results from Surveys 1 and 2.  Question 1 addressed the 
confidence level of the attendees to identify screening methods for HCV.  A 5-point 
Likert scale was used to determine confidence levels where 1 = Not confident at all and 5 
= Very confident. The pre- and post-seminar confidence levels showed an increase from 
3.25 to 4.714, respectively, when averaging all the survey results.  Question 3 addressed 
confidence with identifying a positive screen result.  Although the purpose of the lunch 
and learn was to increase screening rates, it was important for providers to have the 
knowledge of what the next steps were for a positive screening in order to get treatment 
for patients to prevent the poor outcomes previously discussed related to chronic HCV. 
The seminar had a positive impact on the confidence levels of identifying positive HCV 
screening results as evidenced by the increased Likert scale.  The pre-seminar scale score 
was 3.25 and the post-seminar scale score was 4.  Question 4 addressed next steps if a 
positive result was discovered.  The seminar was effective on this topic as well for this 
question as answers remained correct.  Question 5 addressed referral resources for 
treatment for positive HCV screens.  On the pre-seminar survey, four of the eight 
responders left this question blank but after the seminar, all seven responders answered to 
refer the patient to gastroenterologists or gastrointestinal specialists.  Questions 6 and 7 
were free text answers regarding motivators for the attendees to screen their patients for 
HCV and barriers preventing screening patients for HCV, respectively.  Answers can be 
seen in the table.  However, especially with regard to the barriers, repeated answers 
revealed reimbursement, insurance, and coding problems were common.  Patient choice 
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was also a barrier listed that could be addressed through education.  However, at this 
time, the researcher focused on the more prevalent answer related to coding and 
reimbursement costs for patients.  Another barrier that could have been addressed as 
evidenced by one answer, “not listed in health maintenance section of chart,” is addressed 
later in this capstone but was not addressed as a barrier during the research and 
implementation phase of this project. 
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Table 2 
Results of Surveys One and Two  
Question Survey 1 (Pre-Seminar) Survey 2 (Post-Seminar) 
1. Confidence level with screening 
for HCV (1=not confident at all, 
5=very confident) 
 
3.25 
 
 
 
4.714285714 
 
 
 
2. Test to be ordered to screen for 
HCV 
 
 
 
HCV antibody (100% of surveys 
had correct answer; one also put 
hepatitis panel as a second 
answer) 
 
HCV antibody (100% of surveys had 
correct answer) 
 
 
 
3. Confidence level with 
identifying an abnormal HCV 
value (1=not confident at all, 
5=very confident; average score in 
results box for survey 1 and 2)  4 
4. If a screen for HCV is found to 
be abnormal, what are next steps? 
 
 
 
 
call pt and call GI, ?,HCV RNA, 
HCV genotype, viral load, HCV 
PCR, refer to GI 
 
 
refer to GI, viral load, viral load PCR,  
HCV genotype/RNA 
 
 
 
5. What are the referral resources 
in this area for diagnosis of HCV? 
 
4 of 8 surveys left blank, others 
answered GI referral 
 
refer to GI (response from all 7 surveys) 
 
 
6. Top 3 motivators for you to 
participate in screening for HCV? 
 
 
 
 
 
 
 
 
 
 
"right thing to do," great pt care, 
to help pt, age/demographic, 
lifestyle, possible exposure, 
symptoms, early identification/ 
referral/treatment, task force 
recommendation, pt agreement, 
disease finding, improved pt 
outcomes, reduce risk of liver 
cancer, reduce transmission, 
further, education about HCV, 
what to expect if dx with HCV  
 
age group, early dx, avoid/prevent 
complications of chronic liver disease, 
education/knowledge, educating 
patients, patient care,  good pt care, 
identify disease, treat disease, US task 
force recommendation, improve pt 
outcomes, worsening of pt conditions, 
reduce carrier co-infections 
 
 
 
 
7. What are the top 3 barriers  that 
may keep you from screening for 
HCV? 
 
 
 
 
 
 
 
 
"my mind," not listed in health 
maintenance section of chart, 
insurance, cost/no insurance, not 
being aware of the need, 
insurance, patient unwillingness 
to be screened, insurance not 
covering testing, pt not wanting 
testing, time availability, 
reimbursement, time, pt 
willingness, "I don't test patients- 
not a provider," cost/no insurance 
coding for reimbursement, insurance, 
treatment decisions, "not a provider," 
coverage-insurance, patients not 
wanting testing, stigma, coverage, pt 
doesn’t want testing, time, 
reimbursement, pt choice, time,  
 
 
 
 
 
 
8. What was the most useful part of 
the educational program today? 
 
 
 
n/a on part 1 
 
 
 
 
reinforcing importance of screening, 
codes to help with screening diagnosis 
coverage, refresher/classifying need of 
screening baby boomers learning about 
HCV 
9. How could the program be 
improved to better serve your 
needs? 
n/a on part 1 
 
 
"you did awesome", visuals 
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Extent to Which Objectives Were Achieved 
 It is clear the objectives of this capstone project were achieved.  The providers 
agreed at the lunch and learn that screening this birth cohort per the national guideline 
was important and barriers were identified and addressed to help increase the screening 
rates.  The researcher of this project saw an increase of more than 30 percentage points in 
the screened population.  However, the sample size for the post-lunch and learn screening 
rate evaluation was much smaller.  This could have been due to providers taking time off 
from work during the time frame so there were less patient appointments in total.  
Addressing the barrier of coding seemed to be effective in helping providers code 
appropriately for screening of HCV.  This researcher assumed patient screening rates 
would continue to improve over time as the providers refreeze their new habit to include 
HCV screening as part of annual lab work addressed at well-visits.  As the providers 
refreeze their screening habits, hopefully the entire population of patients that meet 
criteria for screening will be screened.  If the data review process of ascertaining if HCV 
screening was offered and completed continued over the next year, the researcher 
anticipates the rate would continue to increase as patients complete their annual well 
visits over the next year.  
Key Facilitators and Barriers 
 Key facilitators of the capstone project included the primary care clinic manager 
and the three main providers at the clinic who agreed to screen the population based on 
the guideline (USPSTF, 2013).  The three providers who attended the lunch and learn 
agreed to screen and found the handouts helpful in ordering the testing with the 
appropriate codes for the birth cohort.  The fourth and fifth providers who were not 
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regular, full-time providers at this clinic did not attend or verbalize their agreement but it 
did not appear their rates greatly impacted the results of this project.  One provider 
resigned from the clinic before the post lunch and learn review.  The other provider only 
assessed patients during three days of the eight-week period and none of her patients 
were there for a well-visit.  Although the barrier addressed was coding appropriately for 
the screening test, the researcher did not evaluate the codes used before and after the 
lunch and learn seminar to code for the HCV testing.  
 Another key group of facilitators to this capstone project included the MAs who 
were in attendance at the lunch and learn.  By having them attend the lunch and learn, 
their knowledge of HCV screening and its importance would help in answering questions 
for patients.  The MAs and laboratory technician in attendance at the education seminar 
could also better understand the next steps for positive results should they arise and help 
direct the patients appropriately to their providers.  The MAs could also send a letter or 
call patients with normal (negative lab results) or schedule the patients with the providers 
in the case of a positive result to complete the next steps.  
 This researcher was also a key facilitator in this quality improvement process at 
the primary care clinic.  She spent 40+ hours completing chart reviews on patients at the 
clinic for well-visits, planning and executing the lunch and learn, and speaking with the 
staff to follow up on and identify barriers to screening.  She also created ideas to address 
these barriers that were sensible to this particular clinic (i.e., creating a handout about 
coding appropriately).  The researcher was also on site and available to the providers and 
staff to answer any questions or clarify information about the HCV screening and 
guideline.  This researcher realized objective one addressing increasing screening rates 
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could have been increased even more by utilizing the EMR to create a screening reminder 
for providers seeing patients at their well-visits.  Although no major barriers were 
encountered during this project, one barrier the researcher identified post-EMR chart 
review that might have deterred providers from screening was the use of formatted smart 
text.  All the providers used a pre-made format of questions and objectives to address 
with patients at well-visits and unless the pre-made format included screening for HCV, it 
was not often addressed.  Two of the providers utilized a smart text that included 
addressing HCV screening and one did not.  This appeared to impact screening rates for 
HCV for this provider.  
Recommendations 
 In summary, the researcher found this capstone project was beneficial and 
successful regarding the objectives of increasing screening rates for HCV and identifying 
and overcoming a barrier that decreased screening rates in the birth cohort.  All the 
providers and the clinic manager found this project to be useful in improving the quality 
of care provided to the patients regarding screening for HCV in the birth cohort.  The 
providers made strong efforts to offer HCV screening and document screening choices 
made by the patient to increase screening rates for HCV.  In the future, educating the 
providers regarding the use of formatted smart text to help prompt asking patients about 
screening for HCV could be a helpful tool to improve screening rates.  An EMR chart 
reminder could also be utilized to increase screening rates.   
 The researcher did not identify unintended consequences of the capstone project 
but as anticipated, the screening rates for HCV in the birth cohort did improve 
significantly in the eight-week post lunch and learn period.  The researcher assumed the 
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screening rate would increase more after the lunch and learn seminar and address the 
barrier of coding with a tip sheet (see Appendix I).  She anticipates the screening rates 
will continue to rise as providers refreeze their habits of including screening for HCV in 
the birth cohort.  As previously stated, the researcher noted a 30% increase in screening 
rates of the sample birth cohort in the eight-week period of patients screened after the 
lunch and learn seminar compared to the previous chart review.  After completing the 
eight-week period of chart reviews post lunch and learn, informal discussion with the 
providers yielded information that indicated providers were changing habits to always 
include screening for HCV.  However, in reviewing the progress notes associated with 
the well-visits, documentation was not consistent between providers about whether 
patients refused HCV screening.  Providers did not consistently document their 
discussion of HCV screening within the patient’s chart.  In the future, having smart text 
formatting that includes screening discussion surrounding HCV would help clarify if 
patients were refusing based on lack of knowledge, previous screening, or other reasons.  
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CHAPTER V 
 
 
RECOMMENDATIONS AND IMPLICATIONS  
FOR PRACTICE 
 
 
 The objectives of this capstone project were to increase screening rates for HCV 
in patients born between 1945 and 1965 at a primary care clinic in northern Colorado by 
identifying and addressing a barrier that hinders providers from screening this birth 
cohort. These objectives were executed utilizing three main methods:  
1. Investigated barriers that hindered providers from screening patients for 
HCV. 
2. Utilized a lunch and learn educational seminar about HCV that included 
surveys about barriers. 
3. Addressed the barrier of coding properly with a handout for providers and 
clinical staff with information about how to code properly for lab work to be 
completed.  
In this chapter, the researcher provides recommendations for the primary care clinic 
about how to further increase screening rates and how the project would likely prove to 
be beneficial if screening rates for HCV continued to increase.  
Recommendations 
 This researcher recommends the project conducted on increasing HCV screening 
rates for the birth cohort born between 1945 and 1965 continue into the future.  Although 
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the lunch and learn educational seminar about the national guideline regarding screening 
for HCV in the birth cohort (USPSTF, 2013) was a one-time event, the addition of the tip 
sheet found in Appendix I for all providers at the clinic could be helpful in reminding 
them about the importance of screening for HCV the birth cohort.  This would help 
prevent future poor outcomes associated with undetected chronic HCV infections.  This 
researcher makes the following recommendations to improve screening rates for HCV for 
the birth cohort: 
• Educate and encourage all providers, existing and new, at the clinic to 
include HCV screening for the birth cohort born between 1945 and 1965 in 
the smart text format of items to review with patients who come to the clinic 
for well visits; and encourage documentation of either a past screening, a 
patient refusal of screening after discussion with the provider, or a lab order 
placed to have the patient screened for HCV.  
• Use the EMR program to generate an alert reminder for the MAs to ask 
patients about HCV screening before the providers see the patient to help 
with the barrier of time with patients.  After the educational seminar, MAs 
can feel competent to at least ask patients if they are interested in this 
screening as the purpose for the screening was made known.  
• Utilize the “health maintenance” section of the EMR that helps providers 
and MAs ensure patients are up to date on various tests and immunizations 
by creating a HCV screening reminder under the “health maintenance” tab 
to be addressed at all visits by either the provider or the MA.  
37 
 
After implementing this capstone project, it was easy to see that changes in 
behavior patterns and refreezing habits take time.  Although the national guideline 
(USPSTF, 2013) regarding HCV screening in the birth cohort born from 1945 to 1965 is 
not a brand-new guideline to implement, it takes time to integrate any changes into 
practice.  If this capstone project were to continue over time, it is the researcher’s 
expectation that the providers and MAs would refreeze habits to include always asking 
patients in the birth cohort about screening for HCV at well visits just as many other 
health maintenance items are routinely addressed at well-visits, e.g., being up to date on 
vaccinations.  To add an alert or reminder in the EMR under the “health maintenance” 
section of the EMR would add an automatic-type screening similar to always asking 
patients at well-visits about their screening mammograms or other blood work to check 
for diabetes or high cholesterol.  Most providers, as observed by the researcher, have 
frozen habits to include this kind of screening routinely and do not generally need an 
EMR alert or reminder.  At this time, the phases of the capstone project are completed.  
The researcher has no further plans for evaluation or improving processes regarding HCV 
screening outside of this project at this time.    
As the mission of the system is to provide excellent patient care, the screening of 
all patients born between 1945 and 1965 for HCV at least once in a lifetime per the 
National Guideline Clearinghouse (USPSTF, 2013) is both feasible and beneficial to 
patients and meets the mission of the system.  Although it is a change of habit and 
perhaps even increases workload for the providers and MAs initially, the long-term 
benefits of HCV screening far outweigh any risks for an individual patient at system and 
population levels.  The positive identification and referral of patients infected with 
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chronic HCV to a gastroenterologist for treatment has many long-term benefits for 
patients.  Treatment of HCV can prevent poor outcomes and health disparities related to 
chronic HCV infection like liver cirrhosis, cancers, and need for transplant (Sanjiv et al., 
2016).  If the project was to continue, perhaps a continued education for staff could be 
completed as a refresher by one of the providers or the office manager so all staff stay up 
to date on protocol for screening and treatment if a positive result is yielded.  
As the primary care clinic is part of a bigger healthcare system, this capstone 
project could definitely be applicable to other primary care clinics within this system.  As 
previously stated, the NGC (USPSTF, 2013) recommends screening all patients born 
between 1945 and 1965 for HCV once in their lifetime.  After completing chart reviews 
of the EMR of a sample of patients born in the birth cohort at the primary care clinic, the 
researcher found there was no standard procedure or approach to ensure all patients who 
call the primary care clinic their primary care office were being screened.  The researcher 
found it easy to extrapolate this finding of lacking a standard procedure to other primary 
care clinics in the area, within the healthcare system, and even clinics located throughout 
the nation.  Per the NGC, this recommendation to screen all people born between 1945 
and 1965 is necessary and valuable to contributing to a healthier individual and 
population.  To make screening more likely to happen on a large-scale level, educational 
seminars like the lunch and learn conducted at this primary care clinic could be 
conducted including the handouts to help educate all providers and MAs who care for this 
population.  It is important to educate providers since an early identification of positive 
results for a patient could mean complete cure rate for the majority of patients, which 
lessens the risk for liver disease, cancer, and need for transplant (Sanjiv et al, 2016).  
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Contribution to Personal Goals 
 This capstone project contributed to the researcher’s personal goals regarding 
development into a nurse leader and advanced practice nurse.  This project exemplified 
the researcher’s ability to identify an area lacking standard procedure based on evidence 
about screening for HCV in the birth cohort, disseminate information about the 
recommendation, and help create new habits for providers and clinical staff to increase 
quality of care provided at the clinic.  All of these abilities were utilized specifically as 
related to chronic HCV infection and the ramifications of untreated disease but could 
easily be transposed to other evidence-based practice guidelines to improve quality of 
patient care.  The researcher was organized, systematic, and attentive to specific needs of 
the primary care clinic in carrying out this capstone project to fruition.  The researcher 
expects that as the providers continue to increase screening rates for their patients, other 
clinics will begin to do the same within the healthcare system as evidence-based practice 
is an ever-important part of providing quality care for patients.  In looking to the future as 
an advanced practice provider, this researcher is confident in being able to implement 
other similar evidence-based information into practice after completing this capstone 
project.  This primary care clinic is part of a healthcare system that strives to be 
innovative in providing quality and up to date care.  The researcher hopes the practice 
will continue to increase in screening rates for HCV as well as further disseminate 
information about the importance of screening for HCV in the birth cohort born between 
1945 and 1965.  The researcher hopes this kind of welcome reception to implement 
evidence-based guidelines and practice into practice for the best care of their patients 
becomes the standard for all primary care clinics.  
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Five Criteria for Executing a Successful Doctor  
of Nursing Practice Final Project 
 In 2014, Waldrop, Caruso, Fuchs, and Hypes wrote EC as PIE.  This article 
describes five criteria for executing a successful Doctor of Nursing Practice (DNP) 
project.  By meeting the five criteria in a final DNP project, the student has met the 
outcomes of the essentials of doctoral education in advanced practice nursing as 
described by the American Association of Colleges of Nursing (cited in Waldrop et al,, 
2014, p. 300).  The letters EC as PIE stand for enhance, culmination, partnerships, 
implements, and evaluates (Waldrop et al., 2014).  Each of these criteria is discussed in 
relation to this researcher’s capstone project.  
 The “E” stands for “enhances health care outcomes, practice outcomes, or 
healthcare policy” (Waldrop et al., 2014, p. 301).  This capstone project enhanced current 
healthcare by utilizing the nationally recognized guideline of screening all patients born 
1945-1965 for HCV to improve patient care and decrease healthcare burden at a personal 
level and at a system level.  The project analyzed current literature to guide project 
implementation and sought a better outcome for patients through implementing evidence-
based practice.  
 The “C” represents a culmination of practice inquiry and expertise (Waldrop et 
al., 2014).  The capstone project showed culmination as this researcher has become an 
expert on the subject matter of HCV screening, repercussions of untreated chronic HCV, 
and next steps to follow when a positive screen is identified from a screening.  The 
researcher used information gained from the DNP program and courses to integrate 
evidence into practice.  The project interfaced with the EMR through the use of data 
collection and could further use the EMR to improve screening rates with expertise 
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consultation with information technology experts. After further discussion with the 
manager of the clinic, the use of EMR task reminders to screen for HCV is a possibility 
to be further explored.  
 The “P” stands for partnership and engagement within interdisciplinary teams or 
collaboration within interprofessional teams (Waldrop et al., 2014, p. 302).  From the 
project process, this researcher worked with various members of the primary care team. 
The laboratory technician, the MAs, the coding expert, and the clinic manager were all 
vital parts of the research process.  The researcher also discovered medical specialty 
groups in the northern Colorado area for referral of positive HCV screening results.  
 The “I” stands for implementation.  Implementation could also be application or 
translation into practice (Waldrop et al., 2014, p. 302).  As discussed, this researcher saw 
a gap in screening efforts at a clinic level and implemented a new practice of screening to 
improve screening rates.  This was applicable at the clinic level and if screening levels 
increase at more than just the single clinic, it could have population and system-wide 
benefits.  Translating the evidence of increased screening rates for HCV to a system level 
can have huge savings to the healthcare system in a monetary sense and a population 
health sense.  
 The final letter “E” from EC as PIE stands for evaluation of healthcare practice 
outcomes (Waldrop et al., 2014, p.302).  The evaluation criteria were met by increased 
data percentages of patients being screened at this clinic for HCV.  The researcher 
utilized a two-fold EMR review to evaluate a clinic level change and show an improved 
outcome.  The long-term outcomes of increasing screening rates are harder to monetarily 
account for but the literature review and data showed the outcomes of increased 
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screening allowed for increased treatment of chronic infection of HCV to decrease 
mortality associated outcomes.  
Summary 
 Hepatitis C virus screening in the birth cohort born between 1945 and 1965 is a 
Grade B recommendation from the National Guideline Clearinghouse (USPSTF, 2013) 
and well worth the effort in primary care clinics for individual patients as well as the total 
population.  This capstone project was successful per the researcher’s evaluation as 
screening rates for HCV drastically increased following a lunch and learn educational 
seminar and a barrier preventing screening was successfully identified and overcome 
through the use of an informational handout.  There is little risk and much to gain for 
other primary care clinics to begin routinely screening this birth cohort for HCV as the 
patients who screen positive could be treated to prevent individual costs both physically 
and fiscally as well as decreasing burden on the healthcare system as a whole.  The 
researcher viewed this project as successful based on the increase in screening rates and 
the overall increase in knowledge of providers regarding HCV as evidenced by the 
survey responses.  After conducting the second eight-week chart review, the researcher 
found smart text formats that helped guide providers in their topics to discuss with 
patients at a well-visit had a large impact on whether or not HCV screening was 
addressed.  If the EMR and specifically smart text formatting or targeting productive use 
of the EMR as a reminder tool for HCV were utilized, rates of screening could increase 
even more in the future.  However, the researcher enjoyed seeing this project come to 
fruition as she honed her leadership and advanced practice skills as she prepared to 
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become an advanced practice provider in a similar setting to the primary care clinic 
where this project was implemented.  
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Author(s) Hypothesis Objectives Questions Variables Design Sample 
setting 
Findings Other 
commentary 
AASLD/IDSA 
HCV Guidance 
Panel (2015) 
This study was 
done to create 
recommendations 
for the screening 
and treatment of 
HCV. 
Screening of birth 
cohort and high 
risk populations. 
Screening done per 
FDA approved 
testing method. 
Annual testing for 
IV drug users. 
Educate about liver 
damage prevention 
for patients with + 
result. Prompt 
treatment of HCV 
positive patients by 
qualified providers. 
Antiviral Tx 
recommended for 
all patients with tx 
regimens.   
Do providers 
appropriately 
screen for 
HCV and 
follow up with 
appropriate 
treatment? 
No variable, 
just 
recommendati
ons.  
 
No design method, 
just 
recommendations.  
n/a Same as stated in 
objectives. All 
patients with 
positive HCV 
should be treated 
promptly to 
prevent further 
health 
deteriorations and 
costs to patients 
and health care 
system.  
 
Bechini et al 
(2015) 
Training and 
implementation 
of HCV and Hep. 
B guidelines for 
screening is very 
important for 
providers. 
Discover if training 
and guidelines are 
available and 
utilized by 
providers regarding 
HCV and Hep B 
screening.   
Do providers 
adequately 
screen for 
HCV and 
HBV? 
Guidelines 
vary by 
country.  
This was a meta-
analysis of 
guidelines in 
databases and 
disseminated to 
providers and 
whether training 
was available on 
when to use.  
A literature 
review was 
performed 
followed by 
a survey of 
healthcare 
professional 
inquiring 
about the 
knowledge 
of HCV 
screening 
practices.  
Further education 
is needed for 
health care 
professionals re: 
HCV screening 
and treatment 
practices and 
protocols.  
 
Brouard et al 
(2015) 
Estimate of 
prevalence of 
HCV positive 
individuals who 
do not know 
infection status 
and increase 
Comparative data 
of 2004 prevalence 
of HCV status and 
knowledge of 
status with 2014 
data.  
What can be 
done to 
increase 
screening rates 
of HCV in 
appropriate 
populations to 
Screening 
processes 
from 2004 to 
2014 have 
changed.  
Data surveillance n/a A new screening 
strategy in France 
can increase 
diagnosis rates, 
but more 
availability is 
needed for 
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screening 
practice to 
increase 
diagnosis and 
treatment.  
properly 
diagnose and 
treat HCV? 
treatment upon 
further 
examination.  
Gane et al 
(2014) 
Can increased 
screening rates 
help to decrease 
the disease 
burden of HCV? 
Descriptive focus 
of showing the 
disease burden of 
HCV rates 
increasing without 
further screening. 
How will HCV 
screening rates 
change the 
population 
outcome of 
disease in birth 
cohort and high 
risk 
individuals? 
A model to 
forecast HCV 
disease 
burden to 
attempt to 
measure 
prevalence, 
treatment, and 
therapy 
options.  
The use of a 
forecast model 
shows that an 
increase in 
successful 
diagnosis and 
treatment for a 
small population 
will decrease 
disease burden.  
Fifteen 
countries.  
Disease burden 
can be reduced by 
appropriately 
screening and 
treating HCV.  
 
Howie and 
Hutchinson 
(2004) 
If HCV virus 
rates increase at 
current rates, 
disease burden 
and prevalence 
will increase 
disproportionatel
y to cost of 
treatment.  
To show that the 
disease burden of 
HCV is significant; 
there is major 
benefits to 
adequate screening 
and thus, 
treatment.  
IS there 
enough 
resources to 
screen and treat 
appropriate 
populations? 
No variable, 
just predictive 
values 
n/a n/a HCV is costly to 
the health care 
system and to the 
patient. However, 
burden of liver 
cirrhosis in the 
next 10-20 years 
is more costly 
than treatment.  
 
Smyth et al 
(2014) 
The cost 
comparison of 
treatment of 
HCV versus the 
cost of clinically 
significant 
disease of HCV 
makes early 
diagnosis and 
treatment a 
promising 
venture.  
Provide real world 
cost estimates of 
ambulatory 
management of 
early to moderate 
stages of HCV 
compared to end 
stage and severe 
HCV clinical 
manifestations to 
show the relativity 
of price of 
treatment to 
prevent chronic 
liver disease.  
Is treatment 
feasible to 
prevent costs 
and mortality 
and morbidity 
of late stage 
liver disease 
from HCV? 
Variable is 
cost of 
clinically 
significant 
illness of 
HCV patients 
compared to 
cost of 
treatment.  
Cross sectional 
study in Ireland.  
Patients in 
Ireland. 
Current treatment 
costs of HCV are 
expensive, but 
comparatively to 
the costs of end 
stage liver disease 
and complications 
of untreated 
HCV, the costs of 
early treatment 
make screening a 
worthwhile 
endeavor.  
Although 
disease rates of 
HCV have gone 
down, it is 
estimated that 
many patients 
do not know 
their disease 
status and will 
not until they 
become 
symptomatic 
with liver 
failure.  
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Consent Form For Human Participants In Research  
University of Northern Colorado School of Nursing   
Project Title: Hepatitis C Screening in Primary Care 
Researcher: Elizabeth Cirbo, BSN, DNP-S  Email: cirb3015@bears.unco.edu 
Research Advisor: Karen Hessler, PhD, FNP Email: karen.hessler@unco.edu  
Phone #: 970-351-2137 
Purpose and Description: Thank you for participating in this survey. These questions 
concern basic clinician knowledge regarding screening for Hepatitis C Virus in primary 
care. The purpose of the survey is to further evaluate process improvement outcomes as 
part of a DNP Capstone. Participation in this survey has no anticipated risk or 
inconvenience to you, and should only take about 5-10 minutes of your time.  
Once the study is completed, results will be shared with you if you desire. There is no 
anticipated risk outside of what might occur in everyday interactions associated with 
completing the surveys and there will not be any compensation for doing so. There is no 
direct benefit to being in the study but you may help increase quality of patient care. 
Your consent form will not be stored with your responses, and your name will not be on 
your surveys to help protect your anonymity. The survey’s will be kept in a locked office 
in the school of nursing separated from your consent forms, only accessible by the 
researcher and research advisor. If you have any questions or concerns, please contact the 
researcher or the research advisor. The advisor may ask your name, but all complaints are 
kept in confidence.  
Participation is voluntary. You may decide not to participate in this study and if you 
begin participation you may still decide to stop and withdraw at any time. Your decision 
will be respected and will not result in loss of benefits to which you are otherwise 
entitled. Having read the above and having had an opportunity to ask any questions, 
please sign below if you would like to participate in this research. A copy of this form 
will be given to you to retain for future reference. If you have any concerns about your 
selection or treatment as a research participant, please contact Sherry May, IRB 
Administrator, Office of Sponsored Programs, 25 Kepner Hall, University of Northern 
Colorado Greeley, CO 80639; 970-351-1910.  
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Baby Boomer HCV Screening Tip Sheet for Billing and Coding 
 
E&M Codes: for well-visits for the baby boomer population (born 1945 to 1965) 
include:  
• 99386, 99387 new patients for comprehensive preventative visits 
• 99396, 99397 established patients for comprehensive preventative visits 
• G0438 initial Medicare well-visit 
• G0439 subsequent Medicare well-visit 
 
ICD-10 Codes: 
If patient has a well-visit that has no abnormal issues addressed (ie Z00.00), the codes 
associated with the anti-HCV order are as follows: 
1. Z00.00 
2. Z11.59  Encounter for screening other viral disease (this code by itself is not 
enough, must be secondary to Z00.00) 
This is used for the patient who is completely asymptomatic of any symptoms that could 
be included in chronic HCV infection differential diagnosis.  
 
If the patient has any symptoms at their well-visit associated with the differential that 
could include chronic HCV, or is an established patient that has had vague symptoms that 
could be associated with HCV, the coding will be based on the symptoms. Here are 
examples of acceptable codes to use for anti-HCV (This list is not comprehensive or 
guaranteed, but can be used as examples of codes to apply to the anti-HCV test). 
• R53.83  Other fatigue 
• M25.50  Pain in unspecified joint (this is related to the symptom of 
generalized arthralgia that can be a vague symptom of chronic HCV 
infection) 
• K76.9  Liver disease, unspecified (or a more specific liver function related 
code can be used if patient has had altered LFTs in past) 
• K77  Liver disorders in disease classified elsewhere (or a more specific 
liver function related code can be used if patient has had altered LFTs in 
past) 
 
  
 
 
